Meissnitzer T, Seymer A, Keinrath P, Holzmannhofer J, Pirich C, Hergan K, Meissnitzer M W
1 Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
2 Department of Sociology and Cultural Science, University of Salzburg, Salzburg, Austria.
Br J Radiol. 2015 Jul;88(1051):20150147. doi: 10.1259/bjr.20150147. Epub 2015 Apr 17.
To prospectively analyse the diagnostic value of semi-quantitative breast-specific gamma imaging (BSGI) in the work-up of suspicious breast lesions compared with that of mammography (MG), breast ultrasound and MRI of the breast.
Within a 15-month period, 67 patients with 92 breast lesions rated as Category IV or V according to the breast imaging reporting and data system detected with MG and/or ultrasound were included into the study. After the injection of 740-1110 MBq of Technetium-99m ((99m)Tc) SestaMIBI intravenously, scintigrams were obtained in two projections comparable to MG. The BSGI was analysed visually and semi-quantitatively by calculating a relative uptake factor (X). With the exception of two patients with cardiac pacemakers, all patients underwent 3-T breast MRI. Biopsy results were obtained as the reference standard in all patients. Sensitivity, specificity, positive- and negative-predictive values, accuracy and area under the curve were calculated for each modality.
Among the 92 lesions, 67 (72.8%) were malignant. 60 of the 67 cancers of any size were detected by BSGI with an overall sensitivity of 90%, only exceeded by ultrasound with a sensitivity of 99%. The sensitivity of BSGI for lesions <1 cm declined significantly to 60%. Overall specificity of ultrasound was only 20%. Specificity, accuracy and positive-predictive value were the highest for BSGI (56%, 80% and 85%, respectively). X was significantly higher for malignant lesions (mean, 4.27) and differed significantly between ductal types (mean, 4.53) and the other histopathological entities (mean, 3.12).
Semi-quantitative BSGI with calculation of the relative uptake factor (X) can help to characterize breast lesions. BSGI negativity may obviate the need for biopsy of breast lesions >1 cm with low or intermediate prevalence for malignancy.
Compared with morphological imaging modalities, specificity, positive-predictive value for malignancy and accuracy were the highest for BSGI in our study. BSGI negativity may support the decision not to biopsy in selected lesions with a low or low-to-moderate pre-test probability for malignancy.
前瞻性分析半定量乳腺特异性γ成像(BSGI)在可疑乳腺病变检查中的诊断价值,并与乳腺钼靶摄影(MG)、乳腺超声及乳腺MRI进行比较。
在15个月的时间内,纳入67例经MG和/或超声检查发现有92个乳腺病变的患者,这些病变根据乳腺影像报告和数据系统被评为IV级或V级。静脉注射740 - 1110 MBq的锝-99m(99mTc)甲氧基异丁基异腈后,在与MG相当的两个投照位获取闪烁图像。通过计算相对摄取因子(X)对BSGI进行视觉和半定量分析。除两名有心脏起搏器的患者外,所有患者均接受了3T乳腺MRI检查。所有患者均以活检结果作为参考标准。计算每种检查方法的敏感性、特异性、阳性和阴性预测值、准确性及曲线下面积。
在92个病变中,67个(72.8%)为恶性。67个任何大小的癌症中有60个被BSGI检测到,总体敏感性为90%,仅次于敏感性为99%的超声。BSGI对<1 cm病变的敏感性显著下降至60%。超声的总体特异性仅为20%。BSGI的特异性、准确性和阳性预测值最高(分别为56%、80%和85%)。恶性病变的X值显著更高(平均为4.27),导管型(平均为4.53)与其他组织病理学类型(平均为3.12)之间差异显著。
通过计算相对摄取因子(X)进行半定量BSGI有助于对乳腺病变进行特征性描述。对于恶性患病率低或中等的>1 cm乳腺病变,BSGI阴性可能无需进行活检。
在我们的研究中,与形态学成像方法相比,BSGI的特异性、恶性病变的阳性预测值和准确性最高。对于恶性预测试验概率低或低至中等的特定病变,BSGI阴性可能支持不进行活检的决定。